Transcatheter Technologies Wins ‘Best Business Pitch’ Award At “German Venture Day” For Its Prosthetic Aortic Heart Valve, Intrinsic To World’s First ‘Truly Repositionable’ TAVI Device, TRINITY

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system—TRINITY—announced today that its CEO, Wolfgang Goetz, M.D., Ph.D., was awarded top prize for “best business pitch” in the 4th annual “German Venture Day” (GVD) organized by Private Equity Forum NRW.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC